Insights - News

Suvoda named “Most Innovative Clinical Trial Technology Firm of 2026”

Written by Suvoda News | Mar 25, 2026 2:00:00 PM

Conshohocken, PA — March 25, 2026 — Suvoda, a global leader in clinical trial technology, has been recognized as the Most Innovative Clinical Trial Technology Firm of 2026 in the Global Excellence Awards presented by Global Health & Pharma magazine. This accolade recognizes Suvoda’s leadership in advancing clinical trial software solutions that empower sponsors, CROs, patients, and study sites with streamlined operations and real-time insights.

Now in its seventh year, the Global Excellence Awards showcase organizations that are making significant contributions to healthcare, life sciences, and pharmaceutical innovation. Recipients are selected by Global Health & Pharma’s in-house research team through a comprehensive review of industry impact, innovation, and leadership across global markets.

Sofi Parry, Senior Editor at GHP News, commented: “Our judges selected Suvoda for the Global Excellence Awards due to its outstanding impact on clinical trial operations through pioneering technology and strong customer endorsement. This award also acknowledges Suvoda’s sustained growth, strategic expansion, and responsiveness to customer feedback in the evolving clinical technology landscape. Including Suvoda in our Q1 issue of GHP Magazine, we’re proud to highlight the firm’s dedication to supporting everyone involved in clinical trials through its care and sophisticated technology.”

This recognition follows a period of substantial growth and innovation for Suvoda. In 2025, the company completed a strategic merger, launched a new AI assistant and patient app, and continued unifying its platform to deliver end-to-end support across Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), patient payments and travel, and related services that enable confident decision making and efficient trial management.

“Innovation at Suvoda has always been purposeful,” said Jagath Wanninayake, Suvoda CEO. “We strive to lead the industry with practical, human-centered innovation to advance clinical trial technology. We act on what patients, sites, and sponsors tell us will make clinical trials more efficient and more accessible. This recognition reflects our commitment to listening closely and translating those insights into meaningful solutions.”

About Suvoda

Suvoda is a global clinical trial technology company with a market-leading, real-time software platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com and follow Suvoda on LinkedIn.

 

CONTACT:
Robin Abadía
Director, External Communications